(Q47877643)

6 February 2018

title

Activation of human aortic smooth-muscle cells is inhibited by PPARalpha but not by PPARgamma activators (English)

1 reference

6 February 2018

1 reference

6 February 2018

Aida Habib

1 reference

6 February 2018

Giulia Chinetti

1 reference

6 February 2018

Wolfgang Koenig

object named as

Koenig W

1 reference

6 February 2018

author name string

Merval R

1 reference

6 February 2018

Lebret M

1 reference

6 February 2018

Torra IP

1 reference

6 February 2018

Delerive P

1 reference

6 February 2018

Fadel A

1 reference

6 February 2018

Fruchart JC

1 reference

6 February 2018

Najib J

1 reference

6 February 2018

Maclouf J

1 reference

6 February 2018

Tedgui A

1 reference

6 February 2018

language of work or name

English

0 references

publication date

1 June 1998

1 reference

6 February 2018

published in

Nature

1 reference

6 February 2018

volume

393

1 reference

6 February 2018

issue

6687

1 reference

6 February 2018

page(s)

790-793

1 reference

6 February 2018

Peroxisome proliterator-activated receptors, orphans with ligands and functions

cites work

1 reference

7 January 2021

The PPARalpha-leukotriene B4 pathway to inflammation control.

1 reference

7 January 2021

The pathogenesis of atherosclerosis: a perspective for the 1990s

1 reference

7 January 2021

Anti-atheromatous effects of fenofibrate, a hypolipidemic drug. I: Anti-atheromatous effects are independent of its hypolipidemic effect in cholesterol-fed rabbits

1 reference

7 January 2021

Angiographic assessment of effects of bezafibrate on progression of coronary artery disease in young male postinfarction patients

1 reference

7 January 2021

Tissue distribution and quantification of the expression of mRNAs of peroxisome proliferator-activated receptors and liver X receptor-alpha in humans: no alteration in adipose tissue of obese and NIDDM patients

1 reference

7 January 2021

Proliferating or interleukin 1-activated human vascular smooth muscle cells secrete copious interleukin 6.

1 reference

7 January 2021

Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors alpha and delta

1 reference

7 January 2021

Fibrates increase human apolipoprotein A-II expression through activation of the peroxisome proliferator-activated receptor

1 reference

7 January 2021

Fenofibrate. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in dyslipidaemia

1 reference

7 January 2021

Gemfibrozil. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in dyslipidaemia

1 reference

7 January 2021

An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma)

1 reference

7 January 2021

Evidence for involvement of NF-kappaB in the transcriptional control of COX-2 gene expression by IL-1beta

1 reference

7 January 2021

Prostaglandin H synthase 2 is expressed abnormally in human colon cancer: evidence for a transcriptional effect

1 reference

7 January 2021

Transcriptional regulation of prostaglandin synthase 2 gene expression by platelet-derived growth factor and serum

1 reference

7 January 2021

Transcriptional roles of nuclear factor kappa B and nuclear factor-interleukin-6 in the tumor necrosis factor alpha-dependent induction of cyclooxygenase-2 in MC3T3-E1 cells

1 reference

7 January 2021

The Prognostic Value of C-Reactive Protein and Serum Amyloid A Protein in Severe Unstable Angina

1 reference

7 January 2021

Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group

1 reference

7 January 2021

The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation

1 reference

7 January 2021

PPAR-gamma agonists inhibit production of monocyte inflammatory cytokines

1 reference

7 January 2021

Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques

1 reference

7 January 2021

Activated transcription factor nuclear factor-kappa B is present in the atherosclerotic lesion

1 reference

7 January 2021

The nuclear factor kappa-B signaling pathway participates in dysregulation of vascular smooth muscle cells in vitro and in human atherosclerosis

1 reference

7 January 2021

Human acidic ribosomal phosphoproteins P0, P1, and P2: analysis of cDNA clones, in vitro synthesis, and assembly

1 reference

7 January 2021

Targeted disruption of the c-src proto-oncogene leads to osteopetrosis in mice

1 reference

7 January 2021

[Rapid physiological coagulation method in determination of fibrinogen]

1 reference

7 January 2021

Enzyme immunoassays of eicosanoids using acetylcholine esterase as label: an alternative to radioimmunoassay

1 reference

7 January 2021

Identifiers

DOI

10.1038/31701

1 reference

6 February 2018

Dimensions Publication ID

1040460300

0 references

1 reference

6 February 2018